Abstract
Clinical manifestations of vasculitis, as a complication of rheumatoid arthritis (RA), can be postulated as a consequence of immune response abnormalities and endothelial cell dysfunction. In this study we searched for the relationship between the extent of vascular involvement and either serum sICAM-1 or selenium concentrations. We also explored the possible interaction of serum selenium with sICAM-1 to provide a greater understanding of their role in rheumatoid vasculitis (RV). For the study, we measured the serum titers of sICAM-1 using an ELISA assay and the serum selenium concentrations using the ETAAS method in 37 women suffering from RA and 18 normal women serving as controls. All the RA patients were evaluated by extensive clinical, laboratory and capillaroscopic studies. In all patients with extra-articular manifestations, severe or moderate changes in nailfold capillaroscopy were found. Serum sICAM-1 titers in RA patients with mild vasculitis on nailfold capillaroscopy did not differ significantly from those of the healthy subjects, whereas a higher sICAM-1 level seemed to reflect the more intensive vascular changes in capillaroscopy. These data suggest that sICAM-1 serum levels may reflect the extent of the microvascular involvement in RA patients. Compared with controls, all the RA patients had markedly lower serum selenium concentrations, irrespective of the degree of the capillaroscopic vascular changes. A significant inverse correlation between sICAM-1 and selenium was found in the controls (r = −0.54; P<0.02). By contrast, no correlation was noted in RA patients (r=0.10, P not significant). This suggests that the sICAM-1 shedding in RV does not appear to be influenced by selenium, presumably owing to its low serum concentration.
Similar content being viewed by others
Abbreviations
- CRP:
-
Serum C-reactive protein
- DAS:
-
Disease activity score
- ESR:
-
Erythrocyte sedimentation rate
- GSH-Px:
-
Glutathione peroxidase
- NSAIDs:
-
Non-steroidal anti-inflammatory drugs
- RA:
-
Rheumatoid arthritis
- RV:
-
Rheumatoid vasculitis
- TR:
-
Thioredoxin reductase
References
Jennette JC, Falk RJ, Andrassy K et al. (1994) Nomenclature of systemic vasculitis. Proposal of an international conference. Arthritis Rheum 37:187–192
Savage COS, Harper L, Cockwell P, Adu D, Howie AJ (2000) ABC of arterial and vascular disease: Vasculitis. Br Med J 320:1325–1328
Evans TI, Dulai S, Roberts WN (1992) Nailfold capillary microscopy. Rheumatol Rev 1:101–106
Maricq HR, LeRoy EC (1973) Patterns in finger capillary abnormalities in connective tissue by ‘wide-field’ microscopy. Arthritis Rheum 16:619–628
Altomonte L, Zoli A, Galossi A et al. (1995) Microvascular capillaroscopic abnormalities in rheumatoid arthritis patients. Clin Exp Rheumatol 13:83–86
Kuryliszyn-Moskal A, Dreher R, Bernacka K, Klimiuk PA (1993) Vasculopathy in rheumatic diseases: findings in nailfold capillaroscopy and skin biopsy. Reumatologia 31:263–269
Sundy JS, Haynes BF (1995) Pathogenic mechanisms of vessel damage in vasculitis syndromes. Rheum Dis Clin North Am 21:861–881
Blann AD, Herrick A, Jayson MIV (1995) Altered levels of soluble adhesion molecules in rheumatoid arthritis, vasculitis and systemic sclerosis. Rheumatology 34:814–819
Littler AJ, Buckley CD, Wordsworth P, Collins I, Martinson J, Simmons DL (1997) A distinct profile of six soluble adhesion molecules (ICAM-1, ICAM-3, VCAM-1, E-selectin, L-selectin and P-selectin) in rheumatoid arthritis. Rheumatology 36:164–169
Cush JJ, Rothlein R, Lindsley HB, Mainolfi EA, Lipsky PE (1993) Increased levels of circulating intercellular adhesion molecule 1 in the sera of patients with rheumatoid arthritis. Arthritis Rheum 36:1098–1102
Mason JC, Kapahi P, Haskard DO (1993) Detection of increased levels of circulating intercellular adhesion molecule 1 in some patients with rheumatoid arthritis but not in patients with systemic lupus erythematosus. Lack of correlation with levels of circulating vascular cell adhesion molecule 1. Arthritis Rheum 36:519–527
Colville-Nash PR, Scott DL (1992) Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications. Ann Rheum Dis 51:919–925
Gho YS, Kleinman HK, Sosne G (1999) Angiogenic activity of human soluble intercellular adhesion molecule-1. Cancer Res 59:5128–5132
Mapp PI, Grootveld MC, Blake DR (1995) Hypoxia, oxidative stress and rheumatoid arthritis. Br Med Bull 51:419–436
Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG (1973) Selenium: biochemical role as a component of glutathione peroxidase. Science 179:588–590
Whitin JC, Bhamre S, Tham DM, Cohen HJ (2002) Extracellular glutathione peroxidase is secreted basolaterally by human renal proximal tubule cells. Am J Physiol 283:F20–28
Tarp U (1994) Selenium and the selenium-dependent glutathione peroxidase in rheumatoid arthritis. Dan Med Bull 41:264–274
Maddox JF, Aherne KM, Reddy CC, Sordillo LM (1999) Increased neutrophil adherence and adhesion molecule mRNA expression in endothelial cells during selenium deficiency. J Leukoc Biol 1999; 65:658–664
Zhang F, Yu W, Hargrove JL, Greenspan P, Dean RG, Taylor EW, Hartle DK (2002) Inhibition of TNF-α induced ICAM-1, VCAM-1 and E-selectin expression by selenium. Atherosclerosis 161:381–386
Björnstedt M, Xue J, Huang W, Akesson B, Holmgren A (1994) The thioredoxin and glutaredoxin systems are efficient electron donors to human plasma glutathione peroxidase J Biol Chem 269:29382–29384
Maurice MM, Nakamura H, Gringhuis S et al. (1999) Expression of the thioredoxin-thioredoxin reductase system in the inflamed joints of patients with rheumatoid arthritis. Arthritis Rheum 42:2430–2439
Arnett FC, Edworth SM, Bloch DA (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324
van Gestel AM, Haagsma CJ, van Riel PLCM (1998) Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 41:1845–1850
Maricq HR (1981) Widefield capillary microscopy. Technique and rating scale for abnormalities seen in scleroderma and related disorders. Arthritis Rheum 24:1159–1165
Kuryliszyn-Moskal A, Bernacka K, Klimiuk PA (1996) Circulating intercellular adhesion molecule-1 in rheumatoid arthritis – relationship to systemic vasculitis and microvascular injury in nailfold capillary microscopy. Clin Rheumatol 15:367–373
Nassonov EL, Samsonov MY, Chichasova NV et al. (2000) Soluble adhesion molecules in rheumatoid arthritis. Rheumatology 39:808–810
O’Dell JR, Lemley-Gillespie S, Palmer WR, Weaver AL, Moore GF, Klassen LW (1991) Serum selenium concentrations in rheumatoid arthritis. Ann Rheum Dis 50:376–378
Honkanen V, Konttinen YT, Sorsa T et al. (1991) Serum zinc, copper and selenium in rheumatoid arthritis. J Trace Elem Electrolytes Health Dis 5:261–263
Søndergaard K, Stengaard-Pedersen K, Zachariae H, Heickendorff L, Deleuran M, Deleuran B (1998) Soluble intercellular adhesion molecule-1 (sICAM-1) and soluble interleukin-2 receptors (sIL-2R) in scleroderma skin. Rheumatology 37:304–310
Coll-Vinent B, Grau JM, López-Soto A et al. (1997) Circulating soluble adhesion molecules in patients with classical polyarteritis nodosa. Rheumatology 36:1178–1183
Uddhammar A, Sundqvist K-G, Ellis B, Rantapää-Dahlqvist S (1998) Cytokines and adhesion molecules in patients with polymyalgia rheumatica. Rheumatology 37:766–769
Machold KP, Kiener HP, Graninger W, Graninger WB (1993) Soluble intercellular adhesion molecule-1 (sICAM-1) in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Immunol Immunopathol 68:74–78
Veale DJ, Maple C, Kirk G, McLaren M, Belch JJF (1998) Soluble cell adhesion molecules: P-selectin and ICAM-1, and disease activity in patients receiving sulphasalazine for active rheumatoid arthritis. Scand J Rheumatol 27:296–299
Marlin SD, Springer TA (1987) Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell 51:813–819
Polverini PJ (1997) Role of macrophage in angiogenesis-dependent diseases. Experientia Suppl 79:11–28
Tarp U, Overvad K, Hansen JC, Thorling EB (1985) Low selenium level in severe rheumatoid arthritis. Scand J Rheumatol 14:97–101
Köse K, Dogan P, Kardas Y, Saraymen R (1995) Plasma selenium levels in rheumatoid arthritis. Biol Trace Elem Res 53:51–56
Skłodowska M, Gromadzińska J, Biernacka M et al. (1996) Vitamin E, thiobarbituric acid reactive substance concentrations and superoxide dismutase activity in the blood of children with juvenile rheumatoid arthritis. Clin Exp Rheumatol 14:433–439
Honkanen V, Konttinen YT, Mussalo-Rauhamaa H (1989) Vitamins A and E, retinol binding protein and zinc in rheumatoid arthritis. Clin Exp Rheumatol 7:465–469
Borglund M, Akesson A, Akesson B (1988) Distribution of selenium and glutathione peroxidase in plasma compared in healthy subjects and rheumatoid arthritis patients. Scand J Clin Lab Invest 48:27–32
Möttönen T, Hannonen P, Seppälä O, Alfthan G, Oka M (1984) Glutathione and selenium in rheumatoid arthritis. Clin Rheumatol 3:195–200
Peretz A, Siderova V, Nève J (2001) Selenium supplementation in rheumatoid arthritis investigated in a double blind, placebo-controlled trial. Scand J Rheumatol 30:208–212
Tarp U, Overvad K, Thorling EB, Graudal H, Hansen JC (1985) Selenium treatment in rheumatoid arthritis. Scand J Rheumatol 14:364–368
Xu M, Hou J, Wu Y, Ling Y (2000) [Study on the modulation of the inflammatory response in mouse hepatic vasculitis with sodium selenite and vitamin E antioxidants] translation. Zhonghua Bing Li Xue Za Zhi 29;279–283
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Witkowska, A.M., Kuryliszyn-Moskal, A., Borawska, M.H. et al. A study on soluble intercellular adhesion molecule-1 and selenium in patients with rheumatoid arthritis complicated by vasculitis. Clin Rheumatol 22, 414–419 (2003). https://doi.org/10.1007/s10067-003-0799-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-003-0799-x